Label

How We Work

Grant

Back

Print

Vaxess Technologies Inc.


November 2016
to support the preclinical development and manufacture of a thermostable microneedle patch with the aim of lowering barriers to vaccine access by simplifying dosing and administration, alleviating cold chain constraints, and lowering costs
$2,967,741
21
Vaccine Development
Global Health
Boston, Massachusetts
http://vaxess.com/

Visit Our Blog